TOKAI PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Granted Under 2007 Stock Incentive PlanStock Option Agreement • August 11th, 2014 • Tokai Pharmaceuticals Inc • Pharmaceutical preparations
VIA HAND DELIVERY March 27, 2013 (as amended April 3, 2013) Martin D. WilliamsVia Hand Delivery • August 11th, 2014 • Tokai Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. MASTER LICENSE AGREEMENT BETWEEN UNIVERSITY OF MARYLAND, BALTIMORE AND TOKAI PHARMACEUTICALS, INC. UMB Docket Nos.:...Master License Agreement • August 11th, 2014 • Tokai Pharmaceuticals Inc • Pharmaceutical preparations • Maryland
This Master License Agreement (“Agreement”) is effective as of the date of the last signature on the Signature Page (“Effective Date”), and is made by and between the UNIVERSITY OF MARYLAND, BALTIMORE (“UMB”), a constituent institution of the University System of Maryland (“USM”) (which is a public corporation and an instrumentality of the State of Maryland), having an address at 515 West Lombard Street, Fourth Floor, Baltimore, Maryland 21201, and TOKAI PHARMACEUTICALS, INC., a Delaware corporation (“Company”), with its principal place of business at 1 Broadway, 14th Floor, Cambridge, MA 02142.
